disclose the fund performance, as well as other information relating to the condition of such fund at each particular period, i.e., details of investment, financial position, expenses, and opinion of the
for 3rd quarter ended as of September 30, 2019, (1 July - 30 September), which details are as following; Results 3rd Quarter 2019 Reviewed Million baht 3rd Quarter 2018 Reviewed Million baht Increase
last year, with the proportion of general patient revenue accounting of 63.09 percent, 36.05 percent from the Social Security patients, and 0.86 percent from other revenue the details are as follows
. Details are as follows: General patients’ revenue for 2Q2020 ended 30 June 2020 was 1,329.86 million baht, a slightly increase of 0.67 million baht or 0. 05 percent compared to the same period of last year
Product Business Group, the Biodiesel business reported production and sales volume of B100 products increased from the government sector policy to support the higher usage of Biodiesel (B100) in the energy
for 3rd quarter ended as of September 30, 2020, (1 July – 30 September), which details are as following; Results 3rd quarter 2020 3rd quarter 2019 YoY 2nd quarter 2020 QoQ Million Baht % Million Baht
statement for Year 2020 ended as of December 31, 2020, (1 January – 31 December), which details are as following Net Profit (Loss) The Company and subsidiaries (Consolidated) realized net profit of 488.52
statement for Year 2021 ended as of December 31, 2021, (1 January – 31 December), which details are as following ; Results Year 2021 Year 2020 YoY Million Baht % Million Baht % Million Baht % Sale 6,431.56
for the year ended December 31, 2022, which details are as following; Operating results (Consolidated) Y2022 Y2021 % Increase (Decrease) Million Baht % Million Baht % Million Baht % Revenue from sales